The funds described herein are open to “accredited investors” only, through an offering made in accordance with Regulation D, Rule 506(c) of the Securities Act of 1933, as amended. In purchasing securities through a 506(c) offering, we are obligated to verify any participating investor’s status as an “accredited investor” in accordance with Rule 501 of Regulation D. Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. We do not make any representations as to the accuracy or completeness of the information contained on this website and undertake no obligation to update the information. Past performance is not an indicator of any future results. All investments contain risk and may lose value. This does not constitute an offer to sell or a solicitation of interest to purchase any securities or investment advisory services in any country or jurisdiction in which such offer or solicitation is not permitted by law.

Obstacles Are The New Opportunities – David C. Karli

In this Show

David C. Karli is a Physician Entrepreneur and CEO of Greyledge Technologies. Watch as he introduces the concept of how his business started and how he pushed through the difficult obstacles.

When startups are just beginning, the first years are filled with intense challenges. Karli will go over in future posts about the difficulties start-up organizations face, specifically about Greyledge Technologies. He follows Grant Cardone’s advice on how to handle objections to price and sales.  Just like Grant, he has learned to see objections as opportunities.

Stay tuned to learn more about the pathway to success that Greyledge Technologies followed.

Get in contact with David C. Karli through his website, LinkedIn, and learn more about Greyledge Technologies here:

davidkarli.com

https://www.linkedin.com/in/davidkarli/

https://www.greyledgebiotech.com/

(Visited 41 times, 1 visits today)